-
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
25 Jul 2024 19:38 GMT
… Infections required treatment with antibiotics and removal of the … future events or otherwise.
BioMarin®, BioMarin RareConnections® and BRINEURA® are …
Andrew Villani
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455 …
-
FDA Action Alert: Merck, Ardelyx, BioMarin and More
16 Oct 2023 06:34 GMT
… benzoyl peroxide, and the topical antibiotic clindamycin. All three agents, alone … its dermatology unit Ortho Dermatologics.
BioMarin Proposes Voxzogo for Younger Children … highly anticipated FDA decisions involves BioMarin’s Voxzogo (vosoritide), which was …
-
The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
04 Jun 2020 12:53 GMT
… )
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
Black … ) sNDA for its triple combo antibiotic Recarbrio.
Related Link: Attention Biotech …
-
BioMarin Pharmaceutical : European Commission Approves Brineura(TM) (cerliponase alfa), the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children
01 Jun 2017 12:35 GMT
… patients. In each case, antibiotics were administered, the intraventricular access … this patient population.
About BioMarin
BioMarin is a global biotechnology … Traci McCarty Debra Charlesworth
BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc.
(415 …
-
Research Reports Initiation on Biotech Stocks -- ImmunoGen, BioMarin Pharma, CEL-SCI, and Dipexium Pharma
09 Jan 2017 13:26 GMT
… /?symbol=IMGN
BioMarin Pharma
California headquartered BioMarin Pharmaceutical Inc.… average. Additionally, shares of BioMarin Pharma, which develops and commercializes … the development and commercialization of antibiotics in the US, have an …
-
Rx Rundown: AbbVie, Biogen, GSK and more
01 Nov 2024 12:06 GMT
… agency approved Iterum Therapeutics’ oral antibiotic sulopenem etzadroxil and probenecid – marketed … commenced manufacturing operations in Missouri.
BioMarin topped Q3 earnings and revenue …
-
Regulatory tracker: Sanofi, Regeneron chase 2025 chronic hives nod for Dupixent in the US
01 Jul 2024 18:41 GMT
… have historically been given antibiotics, immunosuppressants and immunoglobulin replacement … 8:35 a.m.
BioMarin's Brineura has … course of disease," BioMarin's worldwide R … heliobacter pylori in combination with antibiotics.
UPDATED: Monday, July …
-
X4 enters commercial fold with FDA approval of rare disease drug Xolremdi
29 Apr 2024 19:23 GMT
… targeting the symptoms, often involving antibiotics or immunoglobulins, Ragan explained.
Xolremdi … the business like Vertex and BioMarin and others.”
Aside from WHIM …
-
Turkey and Syria Earthquakes: One Year Later
06 Feb 2024 19:57 GMT
… by FedEx, included specifically requested antibiotics, respiratory medications, anti-seizure therapies … Apotex AstraZeneca Baxter Bayer BD BioMarin BMS Boehringer Ingelheim Carlsbad Technology …
About
© 1995-2025